Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nowak

Showing results (611-620 of 807) with videos related to

Pageof 81
Sort By:
Cytogenetics and Cell Genetics|February 22, 2002
The pericentromeric region of human chromosome 11: evidence for a chromosome-specific duplicationJ Zhang, S Qin, S N Sait, et al.
Cancer Genetics and Cytogenetics|April 27, 2010
Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemiaNorma J Nowak, Sheila N J Sait, Amer Zeidan, et al.
Neuromuscular Disorders : NMD|September 1, 2004
Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actinCarina Wallgren-Pettersson, Katarina Pelin, Kristen J Nowak, et al.
Muscle & Nerve|July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trialMichael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
American Journal of Medical Genetics. Part A|March 9, 2005
Rapid array-based genomic characterization of a subtle structural abnormality: a patient with psychosis and der(18)t(5;18)(p14.1;p11.23)Carolyn M Drazinic, Adife G Ercan-Sencicek, Laura M Gault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
Human Molecular Genetics|June 6, 2013
Cardiac α-actin over-expression therapy in dominant ACTA1 diseaseGianina Ravenscroft, Elyshia McNamara, Lisa M Griffiths, et al.
Neuromuscular Disorders : NMD|March 14, 2000
Severe gamma-sarcoglycanopathy caused by a novel missense mutation and a large deletionK J Nowak, P Walsh, R L Jacob, et al.
Stem Cell Research|March 19, 2021
Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 geneJoshua S Clayton, Carolin K Scriba, Norma B Romero, et al.
Journal of Neuropathology and Experimental Neurology|August 22, 2008
Disease severity and thin filament regulation in M9R TPM3 nemaline myopathyBiljana Ilkovski, Nancy Mokbel, Raymond A Lewis, et al.
Pageof 81

Showing results (611-620 of 807) with videos related to

Sort By:
Pageof 81
Cytogenetics and Cell Genetics|February 22, 2002
The pericentromeric region of human chromosome 11: evidence for a chromosome-specific duplicationJ Zhang, S Qin, S N Sait, et al.
Cancer Genetics and Cytogenetics|April 27, 2010
Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemiaNorma J Nowak, Sheila N J Sait, Amer Zeidan, et al.
Neuromuscular Disorders : NMD|September 1, 2004
Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actinCarina Wallgren-Pettersson, Katarina Pelin, Kristen J Nowak, et al.
Muscle & Nerve|July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trialMichael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
American Journal of Medical Genetics. Part A|March 9, 2005
Rapid array-based genomic characterization of a subtle structural abnormality: a patient with psychosis and der(18)t(5;18)(p14.1;p11.23)Carolyn M Drazinic, Adife G Ercan-Sencicek, Laura M Gault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
Human Molecular Genetics|June 6, 2013
Cardiac α-actin over-expression therapy in dominant ACTA1 diseaseGianina Ravenscroft, Elyshia McNamara, Lisa M Griffiths, et al.
Neuromuscular Disorders : NMD|March 14, 2000
Severe gamma-sarcoglycanopathy caused by a novel missense mutation and a large deletionK J Nowak, P Walsh, R L Jacob, et al.
Stem Cell Research|March 19, 2021
Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 geneJoshua S Clayton, Carolin K Scriba, Norma B Romero, et al.
Journal of Neuropathology and Experimental Neurology|August 22, 2008
Disease severity and thin filament regulation in M9R TPM3 nemaline myopathyBiljana Ilkovski, Nancy Mokbel, Raymond A Lewis, et al.
Pageof 81